Total Funding
82
60
Total FundingSeed raised
Growth Score
-4 pts
Heat Score
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
31766
Meta-Flux provides an AI platform that simulates disease biology to accelerate drug development.
- Lee Sherlock: Founder and CEO
- Brendan Martin: Co-Founder and CTO
About the Company
Meta-Flux provides an AI Biologist platform that integrates complex genetic, protein, and metabolic data to simulate disease biology. The platform uses multi-scale models and knowledge graphs to generate ranked hypothesis summaries and drug-repurposing opportunities. Meta-Flux accelerates the discovery timeline and helps pharmaceutical teams make
clearer go/no-go decisions in early-stage research and development.
